Eli Lilly and Company (LLY) Stock Price, News, Quote & History - Yahoo Finance
Oops, something went wrong
Skip to navigation
Skip to main content
Skip to right column
News
Today's news
US
Politics
World
Tech
Audio
Computing
Gaming
Wordle
Home entertainment
TVs
Phones
Science
Streaming
Streaming reviews
VPN
Wearables
Deals
Prime Day 2025
Best Amazon Prime Day deals
More
AI Apps AR and VR Business Cameras Cyber security Entertainment General Smart home Social media Transportation
Weather
Climate change
Health
Wellness
Mental health Sexual health Dermatology Oral health Hair loss Foot health
Nutrition
Healthy eating Meal delivery Weight loss Vitamins and supplements
Fitness
Equipment Exercise
Women’s health
Sleep
Healthy aging
Hearing Mobility
Science
Originals
The 360
Newsletters
Games
Life
Health
Wellness
Mental health Sexual health Dermatology Oral health Hair loss Foot health
Nutrition
Healthy eating Meal delivery Weight loss Vitamins and supplements
Fitness
Equipment Exercise
Women’s health
Sleep
Healthy aging
Hearing Mobility
Parenting
Family health
So mini ways
Style and beauty
It Figures
Unapologetically
Horoscopes
Shopping
Style
Accessories Clothing Luggage Shoes
Beauty
Hair Makeup Skincare Sunscreen
Health
Dental Fitness Hair loss Hearing aids Mental health Mobility Nutrition Personal care Sleep Women's health
Home & Garden
Bedding Cleaning Gardening Kitchen Outdoor
Pets
Tech
Accessories Audio Auto Computers Phones Smart home TVs
Gift ideas
Stores
Amazon Best Buy Home Depot Macy's Nordstrom Target Walmart Wayfair
Shopping Guides
Best non-toxic cutting boards Best heated socks Best body wash Best cordless stick vacuums Best makeup removers
Deals
Father’s Day gifts
Best Father’s Day gifts Best Father’s Day gifts under $50
Prime Day 2025
Best Amazon Prime Day deals
Food
Travel
Autos
Gift ideas
Buying guides
Entertainment
Celebrity
TV
Movies
Music
How to Watch
Interviews
Videos
Finance
My Portfolio
News
Latest
Stock Market
Originals
Crypto
Tariff Updates
Newsletters
Economies
Premium News
Earnings
Tech
Housing
Markets
Stocks: Most Actives
Stocks: Gainers
Stocks: Losers
Trending Tickers
Futures
World Indices
US Treasury Bonds Rates
Currencies
Crypto
Top ETFs
Top Mutual Funds
Options: Highest Open Interest
Options: Highest Implied Volatility
Sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Private Companies
Research
Screeners
Earnings Calendar
Economic Calendar
Stock Comparison
Advanced Chart
Currency Converter
Stock Picks
Investment Ideas
Research Reports
Personal Finance
Credit Cards
Banking
Student Loans
Personal Loans
Insurance
Mortgages
Mortgage Calculator
Taxes
Videos
Latest
Trending Stocks
Market Sunrise
Morning Brief
Opening Bid
All Shows
Stocks in Translation
Trader Talk
Financial Freestyle
ETF Report
FA Corner
Watch Now
Sports
Fantasy
News
Fantasy football
Best ball
Pro Pick 'Em
College Pick 'Em
Fantasy baseball
Fantasy hockey
Fantasy basketball
Download the app
Daily fantasy
NFL
News
Scores and schedules
Standings
Stats
Teams
Players
Drafts
Injuries
Odds
Super Bowl
GameChannel
Videos
NBA
News
Draft
Scores and schedules
Standings
Stats
Teams
Players
Inuries
Videos
Odds
Playoffs
MLB
News
Scores and schedules
Standings
Stats
Teams
Players
Odds
Videos
World Baseball Classic
NHL
News
Scores and schedules
Standings
Stats
Teams
Players
Odds
Playoffs
College football
News
Scores and schedules
Standings
Rankings
Stats
Teams
College basketball
Soccer
News
Scores and schedules
Premier League
MLS
NWSL
Liga MX
CONCACAF League
Champions League
La Liga
Serie A
Bundesliga
Ligue 1
World Cup
NFL Draft
Yahoo Sports AM
Show all
WNBA
Sportsbook
NCAAF
Tennis
Golf
NASCAR
NCAAB
NCAAW
Boxing
USFL
Cycling
Motorsports
Olympics
Horse racing
GameChannel
Rivals
Newsletters
Podcasts
Videos
RSS
Jobs
Help
World Cup
More news
New on Yahoo
Creators
Tech
Local services
Terms
Privacy
Privacy Dashboard
Feedback
© 2025
All rights reserved.
About our ads
Advertising
Careers
Yahoo Finance
Yahoo Finance
Search query
Select edition
USEnglish
US y LATAMEspañol
AustraliaEnglish
CanadaEnglish
CanadaFrançais
DeutschlandDeutsch
FranceFrançais
香港繁中
MalaysiaEnglish
New ZealandEnglish
SingaporeEnglish
台灣繁中
UKEnglish
News
Finance
Sports
More News Today's news
US
Politics
World
Weather
Climate change
Health
Science
Originals
Newsletters
Games
Life Health
Parenting
Style and beauty
Horoscopes
Shopping
Food
Travel
Autos
Gift ideas
Buying guides
Entertainment Celebrity
TV
Movies
Music
How to Watch
Interviews
Videos
Finance My portfolio
Watchlists
Markets
News
Videos
Screeners
Personal finance
Crypto
Sectors
Sports Fantasy
NFL
NBA
MLB
NHL
College football
College basketball
Soccer
NFL Draft
Yahoo Sports AM
New on Yahoo Creators Tech Local services
Selected edition
USEnglish
Mail
Sign in
My Portfolio
News
Latest Stock Market Originals Crypto Tariff Updates Newsletters Economies Premium News
Earnings Tech Housing
Markets
Stocks: Most Actives Stocks: Gainers Stocks: Losers Trending Tickers Futures World Indices US Treasury Bonds Rates Currencies Crypto Top ETFs Top Mutual Funds Options: Highest Open Interest Options: Highest Implied Volatility Sectors Basic Materials Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Healthcare Industrials Real Estate Technology Utilities Private Companies
Research
Screeners Earnings Calendar Economic Calendar Stock Comparison Advanced Chart Currency Converter Stock Picks
Investment Ideas
Research Reports
Personal Finance
Credit Cards Banking Student Loans Personal Loans Insurance Mortgages Mortgage Calculator Taxes
Videos
Latest Trending Stocks Market Sunrise Morning Brief Opening Bid All Shows Stocks in Translation Trader Talk Financial Freestyle ETF Report FA Corner
Watch Now
…
Upgrade to Premium
LLY Eli Lilly and Company
736.83
+0.11%
Summary
News
Research
Chart
Community
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
We are experiencing some temporary issues. The market data on this page is currently delayed.
NYSE - Nasdaq Real Time Price • USD
Eli Lilly and Company (LLY)
Follow
Add holdings
Time to buy LLY?
736.83
+0.80
+(0.11%)
As of 1:55:58 PM EDT. Market Open.
Time to buy LLY?
Chart Range Bar
1D
5D
4.45%
1M
-9.33%
6M
-18.60%
YTD
-4.56%
1Y
-22.80%
5Y
394.62%
All
18,213.44%
Key Events
Mountain
Advanced Chart
Loading chart for LLY
Previous Close 736.03
Open 736.96
Bid 738.06 x 100
Ask 738.58 x 100
Day's Range 732.26 - 746.59
52 Week Range 623.78 - 969.65
Volume 2,714,488
Avg. Volume 4,421,063
Market Cap (intraday) 660.536B
Beta (5Y Monthly) 0.44
PE Ratio (TTM) 48.13
EPS (TTM) 15.31
Earnings Date Oct 30, 2025
Forward Dividend & Yield 6.00 (0.82%)
Ex-Dividend Date Aug 15, 2025
1y Target Est 888.52
Eli Lilly and Company Overview Drug Manufacturers - General / Healthcare
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of cancer; and Chugai Pharmaceutical Co., Ltd, as well as Strategic Collaboration with Eli Lilly to advance development of its myeloid engager platform for autoimmune disease. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. www.lilly.com
47,000 Full Time Employees December 31 Fiscal Year Ends Healthcare
Sector Drug Manufacturers - General
Industry
More about Eli Lilly and Company
Recent News: LLY View More
All
News
Earnings Calls
Press Releases
SEC Filings
Eli Lilly stock rises after weight loss pill passes key test
Yahoo Finance Video • 21 hours ago
Drugmaker pauses UK sales of weight-loss jab Mounjaro
The Telegraph • 14 minutes ago
Eli Lilly (LLY) Highlights Positive Trial Results For Verzenio And Orforglipron
Simply Wall St. • 26 minutes ago
What Is the Intent Behind AbbVie's Recent Acquisition Spree?
Zacks • 2 hours ago
Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock is a Safer Bet?
Zacks • 3 hours ago
2024 saw growth recovery for almost all top biopharma companies
Pharmaceutical Technology • 3 hours ago
Eli Lilly and Company (LLY): A Bull Case Theory
Insider Monkey • 3 hours ago
Billionaire Stanley Druckenmiller Just Bought the Dip on This Beaten-Down GLP-1 Stock (Hint: It's Not Eli Lilly or Novo Nordisk)
Motley Fool • 3 hours ago
Company News for Aug 27, 2025
Zacks • 4 hours ago
Micron initiated, Eli Lilly upgraded: Wall Street's top analyst calls
The Fly • 4 hours ago
Update: HSBC Upgrades Eli Lilly to Hold From Reduce, Adjusts Price Target to $700 From $675
PREMIUM MT Newswires • 4 hours ago
View More
Performance Overview: LLY
Trailing total returns as of 8/27/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC)
.
YTD Return
LLY 3.98%
S&P 500 (^GSPC) 10.18%
1-Year Return
LLY 22.21%
S&P 500 (^GSPC) 15.19%
3-Year Return
LLY 139.43%
S&P 500 (^GSPC) 59.70%
5-Year Return
LLY 423.12%
S&P 500 (^GSPC) 85.97%
Compare To: LLY Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
LLY Eli Lilly and Company
736.83 +0.11%
Mkt Cap
660.536B
Industry Drug Manufacturers—General
NVO Novo Nordisk A/S
56.44 +1.98%
Mkt Cap
261.04B
Industry Drug Manufacturers—General
PFE Pfizer Inc.
25.02 +0.39%
Mkt Cap
142.24B
Industry Drug Manufacturers—General
MRK Merck & Co., Inc.
84.24 -0.89%
Mkt Cap
210.4B
Industry Drug Manufacturers—General
JNJ Johnson & Johnson
176.95 +0.26%
Mkt Cap
426.144B
Industry Drug Manufacturers—General
ABBV AbbVie Inc.
208.09 -0.13%
Mkt Cap
367.603B
Industry Drug Manufacturers—General
BMY Bristol-Myers Squibb Company
47.61 +0.84%
Mkt Cap
96.897B
Industry Drug Manufacturers—General
NOVO-B.CO Novo Nordisk A/S
356.70 +1.64%
Mkt Cap DKK 1.585T
Industry Drug Manufacturers—General
AMGN Amgen Inc.
287.67 -0.66%
Mkt Cap
154.871B
Industry Drug Manufacturers—General
GILD Gilead Sciences, Inc.
114.22 -0.46%
Mkt Cap
141.725B
Industry Drug Manufacturers—General
AZN AstraZeneca PLC
80.04 -0.01%
Mkt Cap
248.916B
Industry Drug Manufacturers—General
Statistics: LLY View More
Valuation Measures
Current
Quarterly
Annual
As of 8/26/2025 Market Cap
659.82B
Enterprise Value
696.18B
Trailing P/E
48.11
Forward P/E
32.26
PEG Ratio (5yr expected)
1.07
Price/Sales
(ttm) 12.47
Price/Book
(mrq) 36.11
Enterprise Value/Revenue
13.07
Enterprise Value/EBITDA
35.41
Financial Highlights
Profitability and Income Statement
Profit Margin
25.91%
Return on Assets
(ttm) 16.55%
Return on Equity
(ttm) 86.29%
Revenue
(ttm) 53.26B
Net Income Avi to Common
(ttm) 13.8B
Diluted EPS
(ttm) 15.31
Balance Sheet and Cash Flow
Total Cash
(mrq) 3.55B
Total Debt/Equity
(mrq) 217.89%
Levered Free Cash Flow
(ttm) -2.27B
View More
Research Analysis: LLY View More
Earnings Per Share
Consensus EPS
Revenue vs. Earnings
Revenue 15.56B
Earnings 5.68B
Q324
Q424
Q125
Q225
0
5B
10B
15B
Analyst Recommendations
Strong Buy
Buy
Hold
Underperform
Sell
Analyst Price Targets
650.00 Low 888.52 Average
736.83 Current
1,190.00 High
View More
Research Reports: LLY
View More
Eli Lilly: Strong Orforglipron Data in Second Obesity Trial Support On-Schedule Regulatory Filings
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Rating
Price Target
Morningstar• yesterday
Daily – Vickers Top Buyers & Sellers for 08/18/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Argus• 9 days ago
Daily – Vickers Top Buyers & Sellers for 08/14/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Argus• 13 days ago
Daily – Vickers Top Buyers & Sellers for 08/13/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Argus• 14 days ago
View More
Top Analysts: LLY
View More
Overall Score
Discover which analysts rank highest for LLY overall weighted by direction, price target, and price movement. Learn More
Truist Securities 71/100
Latest Rating Buy
Direction Score
Discover which analysts rank highest on predicting the directional movement of LLY. Learn More
Truist Securities 72/100
Latest Rating Buy
Price Score
Discover which analysts rank highest on predicting the price target of LLY. Learn More
Cantor Fitzgerald 100/100
Latest Rating Overweight
View More
People Also Watch
BMY
Bristol-Myers Squibb Company
47.61 +0.84%
MRK
Merck & Co., Inc.
84.24 -0.89%
NVO
Novo Nordisk A/S
56.44 +1.98%
ABT
Abbott Laboratories
131.29 -0.23%
UNH
UnitedHealth Group Incorporated
304.16 +1.24%
Copyright © 2025 Yahoo. All rights reserved.
What's trending Dow Jones
S&P 500
DAX Index
Nvidia
Tesla
DJT
Tariffs
Explore more Mortgages
Credit Cards
Sectors
Crypto Heatmap
Financial News
About Data Disclaimer
Help
Feedback
Sitemap
Licensing
What's New
About Our Ads
Premium Plans
Terms
and Privacy Policy
Privacy Dashboard
More Info
U.S. markets close in 2h 5m
US
Europe
Asia
Cryptocurrencies
Rates
Commodities
Currencies
S&P 500
6,480.23 +14.29 (+0.22%)
Dow 30
45,557.42 +139.35 (+0.31%)
Nasdaq
21,584.85 +40.58 (+0.19%)
Russell 2000
2,372.81 +14.21 (+0.60%)
VIX
14.93 +0.31 (+2.12%)
Gold
3,448.40 +15.40 (+0.45%)
Portfolio
Portfolio
Sign in to access your portfolio Sign in
Top gainers
MDB MongoDB, Inc. 290.00 +75.66 (+35.30%)
NCNO nCino, Inc. 33.11 +4.42 (+15.42%)
SATS EchoStar Corporation 58.34 +7.47 (+14.68%)
LUMN Lumen Technologies, Inc. 5.13 +0.44 (+9.36%)
AEO American Eagle Outfitters, Inc. 13.21 +1.02 (+8.42%)
Top losers
TIGR UP Fintech Holding Limited 11.28 -1.55 (-12.05%)
LI Li Auto Inc. 22.52 -2.13 (-8.64%)
XPEV XPeng Inc. 22.44 -1.90 (-7.79%)
SMMT Summit Therapeutics Inc. 24.88 -2.10 (-7.78%)
UUUU Energy Fuels Inc. 11.67 -0.65 (-5.24%)
Most active
OPEN Opendoor Technologies Inc. 4.3200 -0.3800 (-8.09%)
NVDA NVIDIA Corporation 181.98 +0.21 (+0.11%)
PSNYW Polestar Automotive Holding UK PLC 0.3901 +0.2301 (+143.81%)
WBA Walgreens Boots Alliance, Inc. 11.95 +0.03 (+0.25%)
NIO NIO Inc. 6.42 -0.28 (-4.18%)
Earnings events
My earnings events
Earnings events
Trending tickers
MDB MongoDB, Inc. 289.63 +75.29 (+35.13%)
NVDA NVIDIA Corporation 181.97 +0.19 (+0.11%)
KSS Kohl's Corporation 15.28 +2.24 (+17.18%)
RY.TO Royal Bank of Canada 201.74 +11.35 (+5.96%)
PSNYW Polestar Automotive Holding UK PLC 0.3917 +0.2317 (+144.81%)
Top economic events
Top economic events
United States
Mortgage Market Index
Aug 27, 2025, 7:00 AM EDT Prior: P: 277.1 New: N: 275.8
Mortgage Market Index
Aug 27, 2025, 7:00 AM EDT Prior: Prior: 277.1 New: New: 275.8
MBA 30-Yr Mortgage Rate
Aug 27, 2025, 7:00 AM EDT Prior: P: 6.68 New: N: 6.69
MBA 30-Yr Mortgage Rate
Aug 27, 2025, 7:00 AM EDT Prior: Prior: 6.68 New: New: 6.69
Edit your Dock
Terms
and Privacy Policy
Privacy Dashboard
Ad Terms
Feedback
More Info